Publications by authors named "Ann Dunne"

Claim this Profile
A
A Phase 2 Clinical Trial on the Use of Cibinetide for the Treatment of Diabetic Macular Edema.
Noemi Lois, Evie Gardner, Margaret McFarland, David Armstrong, Christine McNally, Ann Dunne

J Clin Med· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cibinetide Improves Corneal Nerve Fiber Abundance in Patients With Sarcoidosis-Associated Small Nerve Fiber Loss and Neuropathic Pain.
Daniel A Culver, Albert Dahan, Daiva Bajorunas, Maria Jeziorska, Monique van Velzen, Ann N Dunne

Invest Ophthalmol Vis Sci· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ARA 290, a nonerythropoietic peptide engineered from erythropoietin, improves metabolic control and neuropathic symptoms in patients with type 2 diabetes.
Michael Brines, Ann N Dunne, Monique van Velzen, Paolo L Proto, Claes-Goran Ostenson

Mol Med· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ARA 290 for treatment of small fiber neuropathy in sarcoidosis.
Monique van Velzen, Lara Heij, Marieke Niesters, Anthony Cerami, Ann Dunne

Expert Opin Investig Drugs· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Ketamine does not produce relief of neuropathic pain in mice lacking the β-common receptor (CD131).
Maarten Swartjes, Marieke Niesters, Lara Heij, Ann Dunne, Leon Aarts

PLoS One· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ARA 290, a peptide derived from the tertiary structure of erythropoietin, produces long-term relief of neuropathic pain coupled with suppression of the spinal microglia response.
Maarten Swartjes, Monique van Velzen, Marieke Niesters, Leon Aarts, Michael Brines, Ann Dunne

Mol Pain· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ARA 290 improves symptoms in patients with sarcoidosis-associated small nerve fiber loss and increases corneal nerve fiber density.
Albert Dahan, Ann Dunne, Maarten Swartjes, Paolo L Proto, Lara Heij

Mol Med· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of ARA 290 in sarcoidosis patients with symptoms of small fiber neuropathy: a randomized, double-blind pilot study.
Lara Heij, Marieke Niesters, Maarten Swartjes, Elske Hoitsma, Marjolein Drent, Ann Dunne

Mol Med· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis